D-dimer assay interference detected by the discrepancy in D-dimer concentrations at different dilutions: a case report.


Journal

Biochemia medica
ISSN: 1846-7482
Titre abrégé: Biochem Med (Zagreb)
Pays: Croatia
ID NLM: 9610305

Informations de publication

Date de publication:
15 Oct 2024
Historique:
received: 27 02 2024
accepted: 24 05 2024
medline: 22 8 2024
pubmed: 22 8 2024
entrez: 22 8 2024
Statut: ppublish

Résumé

This case report describes interference from heterophilic antibodies in D-dimer assay. The interference was suspected due to discrepancies between D-dimer concentrations in the original sample and diluted samples, as well as inconsistent clinical findings. The patient's medical history, laboratory results, and imaging studies were considered in the investigation. Heterophilic antibodies, likely developed during the SARS-CoV-2 infection, were identified as the probable cause of interference. The interference was confirmed through various methods, including dilution studies, blocking heterophilic antibodies, and comparing results with an alternative D-dimer method. This case highlights the importance of recognizing and addressing interference in D-dimer testing, emphasizing the need for collaboration between clinicians and laboratory specialists.

Identifiants

pubmed: 39171087
doi: 10.11613/BM.2024.031001
pii: bm-34-3-031001
pmc: PMC11334198
doi:

Substances chimiques

Fibrin Fibrinogen Degradation Products 0
fibrin fragment D 0
Antibodies, Heterophile 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

031001

Informations de copyright

Croatian Society of Medical Biochemistry and Laboratory Medicine.

Déclaration de conflit d'intérêts

Potential conflict of interest None declared.

Auteurs

Marija Milić (M)

Clinical Institute of Laboratory Diagnostics, University Hospital Centre Osijek, Osijek, Croatia.
Department of Medicinal Chemistry, Biochemistry and Clinical Chemistry, Faculty of Medicine, University of Osijek, Osijek, Croatia.

Dejana Brkić Barbarić (D)

Clinical Institute of Transfusion Medicine, University Hospital Centre Osijek, Osijek, Croatia.

Iva Lukić (I)

Clinical Institute of Laboratory Diagnostics, University Hospital Centre Osijek, Osijek, Croatia.
Department of Medicinal Chemistry, Biochemistry and Clinical Chemistry, Faculty of Medicine, University of Osijek, Osijek, Croatia.

Mirna Kirin (M)

Siemens Healthineers, Siemens Healthcare d.o.o, Zagreb, Croatia.

Vikica Buljanović (V)

Medical Biochemistry Laboratory, General Hospital Našice, Našice, Croatia.

Vatroslav Šerić (V)

Clinical Institute of Laboratory Diagnostics, University Hospital Centre Osijek, Osijek, Croatia.
Department of Medicinal Chemistry, Biochemistry and Clinical Chemistry, Faculty of Medicine, University of Osijek, Osijek, Croatia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH